In this study, we demonstrated for the first time that blood TDPase and TMPase activities in AD patients were significantly enhanced as compared with those age- and gender-matched control subjects whereas TPK activity was not significantly changed (Fig 1). The gene discussed is ACP3; the disease is Alzheimer disease.